Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;8(9):344.
doi: 10.3390/antiox8090344.

How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity

Affiliations

How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity

Rafael Ramis et al. Antioxidants (Basel). .

Abstract

Pyridoxamine, one of the natural forms of vitamin B6, is known to be an effective inhibitor of the formation of advanced glycation end products (AGEs), which are closely related to various human diseases. Pyridoxamine forms stable complexes with metal ions that catalyze the oxidative reactions taking place in the advanced stages of the protein glycation cascade. It also reacts with reactive carbonyl compounds generated as byproducts of protein glycation, thereby preventing further protein damage. We applied Density Functional Theory to study the primary antioxidant activity of pyridoxamine towards three oxygen-centered radicals (•OOH, •OOCH3 and •OCH3) to find out whether this activity may also play a crucial role in the context of protein glycation inhibition. Our results show that, at physiological pH, pyridoxamine can trap the •OCH3 radical, in both aqueous and lipidic media, with rate constants in the diffusion limit (>1.0 × 108 M - 1 s - 1 ). The quickest pathways involve the transfer of the hydrogen atoms from the protonated pyridine nitrogen, the protonated amino group or the phenolic group. Its reactivity towards •OOH and •OOCH3 is smaller, but pyridoxamine can still scavenge them with moderate rate constants in aqueous media. Since reactive oxygen species are also involved in the formation of AGEs, these results highlight that the antioxidant capacity of pyridoxamine is also relevant to explain its inhibitory role on the glycation process.

Keywords: AGEs; DFT; ROS; inhibition; pyridoxamine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Atom numbering for the four pyridoxamine (PM) tautomers considered for calculations in water (H2PM(±), H2PM(+) and H2PM(0)) and pentyl ethanoate (HPM(0)). Mole fractions χ at physiological pH (7.4), calculated from the pKa values collected by Casasnovas et al. [37], are also indicated.
Figure 2
Figure 2
Transition state for the RAF reaction between the H2PM(±) tautomer of pyridoxamine and the •OCH3 radical at C6, which is the fastest reaction for which a transition state was located. The distance between the oxygen atom of •OCH3 and the C6 atom of H2PM(±) is given in Å.

References

    1. Bohlender J.M., Franke S., Stein G., Wolf G. Advanced Glycation End Products and the Kidney. Am. J. Physiol. Ren. Physiol. 2005;289:645–659. doi: 10.1152/ajprenal.00398.2004. - DOI - PubMed
    1. Stitt A.W. The Maillard Reaction in Eye Diseases. Ann. N. Y. Acad. Sci. 2005;1043:582–597. doi: 10.1196/annals.1338.066. - DOI - PubMed
    1. Kume S., Takeya M., Mori T., Araki N., Suzuki H., Horiuchi S., Kodama T., Miyauchi Y., Takahashi K. Immunohistochemical and Ultrastructural Detection of Advanced Glycation End Products in Atherosclerotic Lesions of Human Aorta with a Novel Specific Monoclonal Antibody. Am. J. Pathol. 1995;147:654–667. - PMC - PubMed
    1. Thorpe S.R., Baynes J.W. Maillard Reaction Products in Tissue Proteins: New Products and New Perspectives. Amino Acids. 2003;25:275–281. doi: 10.1007/s00726-003-0017-9. - DOI - PubMed
    1. Brownlee M. Advanced Protein Glycosylation in Diabetes and Aging. Annu. Rev. Med. 1995;46:223–234. doi: 10.1146/annurev.med.46.1.223. - DOI - PubMed

LinkOut - more resources